Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon B Zeichner

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Breast Cancer Research and Treatment|July 12, 2014
Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancerVakaramoko Diaby, Georges Adunlin, Simon B Zeichner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2017
Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced MelanomaChristine G Kohn, Simon B Zeichner, Qiushi Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2017
Reply to Á. Benedict et alChristine G Kohn, Simon B Zeichner, Qiushi Chen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2017
External Validation of Generic and Cancer-Specific Risk Stratification Tools in Patients With Pulmonary Embolism and Active CancerErin R Weeda, Jonathan T Caranfa, Simon B Zeichner, et al.
Breast Cancer Research and Treatment|September 23, 2016
Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United StatesVakaramoko Diaby, Georges Adunlin, Askal A Ali, et al.
Breast Cancer Research and Treatment|September 12, 2015
Survival of patients with de-novo metastatic breast cancer: analysis of data from a large breast cancer-specific private practice, a university-based cancer center and review of the literatureSimon B Zeichner, Stuart Herna, Aruna Mani, et al.
Breast Cancer Research and Treatment|June 6, 2014
A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancerTadeu Ambros, Simon B Zeichner, John Zaravinos, et al.
Clinical Breast Cancer|September 22, 2014
Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancerSimon B Zeichner, Tulay Koru-Sengul, Nikesh Shah, et al.
Breast Cancer : Basic and Clinical Research|April 30, 2015
Defining the survival benchmark for breast cancer patients with systemic relapseSimon B Zeichner, Tadeu Ambros, John Zaravinos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 12, 2017
Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic LeukemiaBetty Ky Hamilton, Lisa Rybicki, Donna Abounader, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Breast Cancer Research and Treatment|July 12, 2014
Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancerVakaramoko Diaby, Georges Adunlin, Simon B Zeichner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2017
Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced MelanomaChristine G Kohn, Simon B Zeichner, Qiushi Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2017
Reply to Á. Benedict et alChristine G Kohn, Simon B Zeichner, Qiushi Chen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2017
External Validation of Generic and Cancer-Specific Risk Stratification Tools in Patients With Pulmonary Embolism and Active CancerErin R Weeda, Jonathan T Caranfa, Simon B Zeichner, et al.
Breast Cancer Research and Treatment|September 23, 2016
Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United StatesVakaramoko Diaby, Georges Adunlin, Askal A Ali, et al.
Breast Cancer Research and Treatment|September 12, 2015
Survival of patients with de-novo metastatic breast cancer: analysis of data from a large breast cancer-specific private practice, a university-based cancer center and review of the literatureSimon B Zeichner, Stuart Herna, Aruna Mani, et al.
Breast Cancer Research and Treatment|June 6, 2014
A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancerTadeu Ambros, Simon B Zeichner, John Zaravinos, et al.
Clinical Breast Cancer|September 22, 2014
Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancerSimon B Zeichner, Tulay Koru-Sengul, Nikesh Shah, et al.
Breast Cancer : Basic and Clinical Research|April 30, 2015
Defining the survival benchmark for breast cancer patients with systemic relapseSimon B Zeichner, Tadeu Ambros, John Zaravinos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 12, 2017
Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic LeukemiaBetty Ky Hamilton, Lisa Rybicki, Donna Abounader, et al.
Pageof 3